News

Cardinal Health (CAH) Faces An Earnings Test On A Modestly Undervalued View

Cardinal Health earnings event puts the spotlight on sentiment Cardinal Health (CAH) heads into its planned November 5, 2026 earnings release with fresh attention after Mizuho raised expectations and the stock recently pushed through one technical entry and began testing another. Over the past year, Cardinal Health has moved from a quiet compounder to a momentum story, with a 30-day share price return of 14.05% and a 1-year total shareholder return of 62.92% that builds on an approximately 5x...

Yahoo·10:14CAH▼−1.9%

Disposable Specimen Container Market Forecast Report 2026-2030 | Capitalize on Sterile Automation and $3.97B Demand with Leading Players Thermo Fisher, Cardinal Health, SARSTEDT and Greiner Bio-One

Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Disposable Specimen Container Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global disposable specimen container market is experiencing strong growth as healthcare providers, diagnostic laboratories and research organizations prioritize hygienic sample collection, specimen integrity and infection control. The market is projected to increase from $2.66 billion in 2025 to $2.89 billion in 2026, representing a compound annual

Yahoo·04:05CAH▼−1.9%

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.

Yahoo·17:00CAH▼−1.9%

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280

Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.

Benzinga·04:10CAH▼−1.9%

UBS Maintains Buy on Cardinal Health, Raises Price Target to $295

UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.

Benzinga·09:40CAH▼−1.9%

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) closed at $253.71 in the latest trading session, marking a +2.41% move from the prior day.

Yahoo·17:15CAH▼−1.9%

Level AI's CX Advisory Board adds Shane Abeyratne, SVP at Cardinal Health

Level AI, the customer intelligence platform for contact centers, today announced that Shane Abeyratne, Senior Vice President, Global Business & Finance Services at Cardinal Health, has joined the company's CX Advisory Board.

Yahoo·09:01CAH▼−1.9%

What to Expect From Cardinal Health’s Q1 2027 Earnings Report

Cardinal Health is set to report its Q1 results next month, with analysts expecting double-digit year-over-year EPS growth.

Yahoo·08:12CAH▼−1.9%

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahoo·08:40CAH▼−1.9%

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.

Yahoo·08:40CAH▼−1.9%

Reasons to Retain Cardinal Health Stock in Your Portfolio for Now

CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.

Yahoo·09:44CAH▼−1.9%

Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know

Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.

Yahoo·17:00CAH▼−1.9%

Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings?

Even though Cardinal Health (currently trading at $220.37 per share) has gained 6.8% over the last six months, it has lagged the S&P 500’s 22.1% return during that period. This may have investors wondering how to approach the situation.

Yahoo·12:24CAH▼−1.9%

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade

Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.

Yahoo·17:00CAH▼−1.9%

Cardinal Health (CAH) Stock Looks About Right At Today’s Price

Cardinal Health has been a powerful performer over the past several years. The question now is whether the current share price lines up with what the business is earning. With the stock pulling back slightly in the short term after a strong multi year run, investors are increasingly focused on what its earnings actually justify. Cardinal Health has returned about 378.2% over the past 5 years, which puts real pressure on the current valuation story to be supported by the earnings profile. The...

Yahoo·13:12CAH▼−1.9%

Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?

CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.

Yahoo·11:45CAH▼1.9%

Medical Textile Market Global Report 2026: A $39.53 Billion Revenue Surge to $64.28 Billion by 2030 at 26.9% CAGR, Benchmark 3M, Medline Industries, Cardinal Health, and DuPont to Secure Market Share

Profiles 3M, Medline, Cardinal Health, Medtronic and DuPont, covering competitors, segments, regional shares, trends and opportunities. Medical Textile Market Medical Textile Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Medical Textile Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. Medical Textile Market to Reach $64.28 Billion by 2030 as Healthcare Demand Accelerates The global medical textile market is experiencing exponential growth, supported by rising

Yahoo·06:51CAH▼−1.9%

Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know

In the latest trading session, Cardinal Health (CAH) closed at $222.04, marking a -1.64% move from the previous day.

Yahoo·18:15CAH▼−1.9%

Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?

According to the average brokerage recommendation (ABR), one should invest in Cardinal (CAH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Yahoo·09:30CAH▼−1.9%

Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds

Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what he described as a “constructive” period. Speaking at the Morgan Stanley Global Healthcare Confere

Yahoo·18:01CAH▼−1.9%

Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand

Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company’s fiscal 2026 performance was supported by double-digit earnings growth across each of its five operating segments, while fiscal 2027 guidance reflects continued growth from a more normalized base. Speaking at a Baird event, Hollar said t

Yahoo·12:02CAH▼1.9%

Jim Cramer Said These 2 Stocks Were Sold Because Of A Rotation – But Is He Right?

Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)’s shares have done well in September and are up by more than 8% since the 10th. On the 15th, Cramer discussed the strength in the shares in a conversation with his co-host David Faber amidst the turmoil in the AI sector on the back of […]

Yahoo·19:15

Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better

Healthcare services and products company Cardinal Health (NYSE:CAH)’s shares are up by more than 10% year-to-date but are down by more than 8% since early September. Cramer discussed the firm’s share price performance in his morning appearance on September 15th and wondered whether the weakness was due to a rotation into AI stocks rather than […]

Yahoo·19:13CAH▼−1.9%

9 Health Care Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

Benzinga·09:35

Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?

Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.

Yahoo·12:17CAH▼−1.9%

How Is Cardinal Health's Stock Performance Compared to Other Health Care Services Stocks?

Cardinal Health has outperformed the Health Care Services industry over the past year, and analysts are highly optimistic about the stock’s prospects.

Yahoo·06:01CAH▼−1.9%

Cardinal Health, Inc. (CAH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Cardinal Health, Inc. (CAH) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:45 AM EDTCompany ParticipantsDavid Frost - Vice President of...

SeekingAlpha·06:57CAH▼−1.9%

Cardinal Health (CAH) Declines More Than Market: Some Information for Investors

In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.

Yahoo·18:00CAH▼−1.9%

Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?

Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.

Yahoo·11:07CAH▼−1.9%

Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”

On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]

Yahoo·17:52CAH▼−1.9%

Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen

Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.

Yahoo·15:22

Cardinal Health CEO Sells $29 Million in Stock After Earnings Send Shares to Record

CEO Jason Hollar leads a wave of insider selling that saw top executives liquidate nearly $60 million worth of company stock.

Yahoo·20:44CAH▼−1.9%

What Is Drawing Attention To Cardinal Health (CAH) Today?

Cardinal Health earnings and capital return in focus Cardinal Health (CAH) has drawn fresh attention after releasing its fourth quarter and full year 2026 results, paired with a new US$5b share repurchase authorization and a confirmed quarterly dividend. The latest numbers give you an updated view of how the healthcare distributor is converting its large revenue base into profit and cash flow. They also show how management is choosing to return capital to shareholders through buybacks and...

Yahoo·22:11CAH▼−1.9%

RBC Capital Initiates Coverage of Cardinal Health (CAH) with Outperform Recommendation

Fintel·18:11CAH▼−1.9%

Cardinal Health’s (CAH) Big Earnings Beat Hides a More Complicated Story

On August 11, Cardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results that on the surface look almost too good to be true. Non-GAAP diluted EPS jumped 40% year over year to $2.91, and full-year adjusted free cash flow hit $5 billion. But a large piece of that quarterly jump came from a one-time tariff refund, […]

Yahoo·13:50CAH▼−1.9%

Cardinal Health's Integration of Higher-Margin Services Will Drive Outperformance, RBC Says

Cardinal Health's (CAH) vertical integration of "higher-growth and higher-margin services" will comp

Yahoo·12:02CAH▼−1.9%

RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.

Benzinga·05:44CAH▼−1.9%

Cardinal Health: Precision Medicine Drives A Sustained Revenue Growth Path

SeekingAlpha·04:55CAH▼−1.9%

1 S&P 500 Stock Worth Investigating and 2 We Turn Down

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Yahoo·20:53

AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different story about future earnings power.

Yahoo·15:46

Cardinal Health CEO details M&A strategy and growth

Jason Hollar, Cardinal Health (CAH) CEO joins Yahoo Finance Executive Editor Brian Sozzi to detail how M&A strategy, specialty pharma growth, and drug volume dynamics are driving profits.

Yahoo·14:29CAH▼−1.9%

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.

Yahoo·11:36

SOLV Plans Health Information Systems Business Spinoff to Drive Growth

Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.

Yahoo·11:35

Did New 7UP Formula, Dr Pepper Shakes and Board Addition Just Shift Keurig Dr Pepper's (KDP) Investment Narrative?

Keurig Dr Pepper has recently reported second-quarter 2026 results showing sales of US$7.31 billion and net income of US$142 million, while rolling out a lime-led reformulation of 7UP and partnering with Portillo’s on limited-time Dr Pepper shakes in the U.S. Alongside these product moves, the company has added Cardinal Health CFO Aaron Alt to its board as it works through a planned split into separate beverage and coffee businesses. With Aaron Alt joining the board during Keurig Dr Pepper’s...

Yahoo·01:12CAH▼−1.9%

Cardinal Health Stock Hits a Record High After Earnings: Is CAH Still a Buy?

Cardinal Health (CAH) gave investors plenty to like in its fiscal fourth-quarter report this week, sending shares to a record high of $258 as Wall Street digests another earnings beat and an encouraging FY27 outlook.

Yahoo·18:10CAH▼−1.9%

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

RVTY launches SuperFlex, a compact automated prenatal screening system aimed at expanding rapid in-house testing for smaller labs and clinics.

Yahoo·10:00

Can BWX Technologies' Nuclear Medicine Expansion Boost Growth?

BWXT expands its commercial nuclear portfolio through nuclear medicine, isotope production and radiopharmaceutical capabilities.

Yahoo·09:29

TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.

Benzinga·08:40CAH▼−1.9%

JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.

Benzinga·07:00CAH▼−1.9%

Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.

Benzinga·06:02CAH▼−1.9%